Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2014-06-20 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
简式权益变动报告书
Major Shareholding Notification Classification · 95% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the changes in shareholding of a significant shareholder (Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd.) in the listed company 嘉事堂药业股份有限公司 (Jia Shi Tang Pharmaceutical Co., Ltd.). The document includes detailed information about the shareholder, the number of shares held before and after the change, the method of share reduction, and the timeline of share transactions. It references compliance with Chinese securities laws and disclosure regulations related to equity changes. There is no indication that this is a full annual or interim financial report, audit report, or earnings release. Instead, it is a formal notification of a change in major shareholding levels, consistent with the definition of "Major Shareholding Notification (MRQ)" which covers notifications of changes in significant share ownership levels crossing thresholds. The document length (8636 characters) and content confirm it is a detailed report of shareholding changes, not merely an announcement or a certification. Therefore, the appropriate classification is MRQ with high confidence.
2014-06-20 Chinese
2013年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is titled '2013 年度权益分派实施公告' which translates to '2013 Annual Equity Distribution Implementation Announcement'. It details the dividend distribution plan approved at the 2013 Annual General Meeting held on April 18, 2014. The document specifies the dividend amount per 10 shares, the record date, the ex-dividend date, the eligible shareholders, and the dividend payment method. It also references the shareholders' meeting resolution as a backup document. The content is focused on the announcement of dividend distribution details rather than the dividend amount announcement itself or the full annual report. Given the detailed dividend distribution plan and implementation information, this fits best under the category of Notice of Dividend Amount (DIV). The document length is short (1571 characters), but it contains substantive dividend distribution details, not just a brief announcement or a link to a report, so it is not a Report Publication Announcement (RPA). Therefore, the classification is DIV with high confidence.
2014-06-04 Chinese
第四届董事会第十四次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the 14th meeting of the 4th Board of Directors of 嘉事堂药业股份有限公司. It details voting results on acquisition proposals and confirms the meeting was held properly. There is no detailed financial data or full report content, only a summary of board decisions and voting outcomes. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board. The document length is short and it is not a full report or financial statement, nor is it a mere announcement of a report publication. Therefore, the classification is MANG with high confidence.
2014-04-28 Chinese
关于收购刘金刚、陈起、杨弟所拥有并实际控制的广州嘉事百洲医疗器械有限公司等七家单位部分股权并增资的公告
M&A Activity Classification · 100% confidence The document is a detailed announcement regarding the acquisition of partial equity interests in several companies by 嘉事堂药业股份有限公司. It includes transaction overview, parties involved, financial data of the target companies, terms of the equity transfer, payment schedule, capital increase, governance structure post-transaction, purpose and impact of the acquisition, risk warnings, and references to related board resolutions, audit reports, and asset appraisal reports. The content is focused on a corporate transaction involving acquisition and capital increase, with no indication of it being a full annual or interim financial report, earnings release, or other types of filings. The document is not a simple announcement of a report publication but a substantive disclosure of a merger/acquisition transaction. Therefore, the appropriate classification is M&A Activity (TAR).
2014-04-28 Chinese
收购广州怡核医疗科技有限公司等五家公司项目资产评估报告
Audit Report / Information Classification · 95% confidence The document is an asset valuation report prepared by an asset appraisal company for a proposed acquisition by 嘉事堂药业股份有限公司 of five companies including 广州怡核医疗科技有限公司. It contains detailed valuation methods, asset and liability assessments, financial data, legal and regulatory references related to asset valuation, and the purpose of providing a value reference for the acquisition. The document is not a general annual report, earnings release, or management discussion but a specialized asset evaluation report related to a transaction. It is not a mere announcement or certification but a full valuation report with substantive financial and asset data. Therefore, it fits best into the category of Audit Report / Information (AR), which includes standalone audit and valuation reports related to accounting and asset assessments outside of full annual reports. Q1 2014
2014-04-28 Chinese
关于收购周宏峰、周宏峻所拥有并实际控制的广州嘉事怡核医疗科技有限公司等五家单位部分股权并增资的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the acquisition of partial equity and capital increase involving several companies. It includes transaction overview, parties involved, financial data of the target companies, terms of the agreement, payment schedule, and impact on the company. The document is not a financial report like an annual or interim report, nor is it a simple announcement of a report publication. It is a corporate announcement about a capital transaction and acquisition activity. The content fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising, financing activities, and capital structure changes related to the acquisition and equity investment.
2014-04-28 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.